Is Artemis Medicare Services a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Artemis Medicare Services Ltd is a average quality company .

Is Artemis Medicare Services undervalued or overvalued?

The key valuation ratios of Artemis Medicare Services Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Artemis Medicare Services share price return in the past 10 years?

Data is not available for this company

Is Artemis Medicare Services a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Artemis Medicare Services Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Artemis Medicare Services?

The latest standalone P/E ratio of Artemis Medicare Services as of 21-Nov-2024 is 61.26.

What is the P/B ratio of Artemis Medicare Services?

The latest standalone P/B ratio of Artemis Medicare Services as of 21-Nov-2024 is 5.46.

What is the 52-week high and low of Artemis Medicare Services?

The 52-week high of Artemis Medicare Services is Rs. 301.95 and the 52-week low is Rs. 140.60.

Artemis Medicare Services Ltd - Stock Valuation and Financial Performance

Name: Artemis Medicare Services
Brand: Artemis Medicare Services

BSE: 542919 | NSE: ARTEMISMED | Hospital & Healthcare Services | Small Cap

Place order

Artemis Medicare Share Price

₹320.40 31.40 10.87%
as on 21-Nov'24 14:23

10 Year X-Ray of Artemis Medicare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	19.2%	21.2%	20.6%	18.4%	16.1%	13%	5.9%	11.9%	13.9%	16.5%	-
Value Creation Index ⓘ	0.4	0.5	0.5	0.3	0.2	-0.1	-0.6	-0.2	0.0	0.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	367	402	459	503	547	563	402	545	714	845	879
Sales YoY Gr.	-	9.4%	14.2%	9.5%	8.7%	3%	-28.6%	35.5%	31.1%	18.3%	-
Adj EPS ⓘ	0.9	1	1.3	1.3	0	1.5	0.4	2.5	2.8	3.6	4.7
YoY Gr.	-	8.7%	28%	0%	-100%	NA	-75.7%	583.3%	15.5%	25.7%	-
BVPS (₹) ⓘ	4	5	6.6	7.9	0	18.7	19.3	21.7	24.7	27.8	52.9
Adj Net Profit ⓘ	19.4	21	26.9	27	21.9	19.6	4.8	32.6	38.1	48.5	65
Cash Flow from Ops. ⓘ	52.8	20.5	57.9	71.9	40.5	56.5	27	60.7	129	108	-
Debt/CF from Ops. ⓘ	1.6	3.3	1.6	1.3	2.8	1.6	4.4	2.9	1.7	2.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	9.7%	9.1%	28.1%	18.3%
Adj EPS ⓘ	16.3%	NA	114.8%	25.7%
BVPSⓘ	24.1%	NA	12.9%	12.5%
Share Price	-	-	108.8%	94.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	13.2	12.4	13.9	12.4	8.3	6.4	1.5	9.5	9.9	11.3	11.7
Op. Profit Mgn % ⓘ	11.8	10.8	11.5	12	12.1	11.1	8.8	12.2	13.2	15.2	16.5
Net Profit Mgn % ⓘ	5.3	5.2	5.9	5.4	4	3.5	1.2	6	5.3	5.7	7.4
Debt to Equity ⓘ	1	0.6	0.7	0.6	0.5	0.4	0.5	0.6	0.7	0.6	0.3
Working Cap Days ⓘ	61	71	76	69	67	76	106	85	79	74	65
Cash Conv. Cycle ⓘ	-15	-8	-4	-7	-4	2	4	5	5	-2	27

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 11.70%

Sales growth is growing at healthy rate in last 3 years 28.10%

Net Profit is growing at healthy rate in last 3 years 114.84%

Debt to equity has declined versus last 3 years average to 0.63

Sales growth is good in last 4 quarters at 11.96%

No data to display

Latest Financials - Artemis Medicare Services Ltd.

	Standalone	Consolidated
TTM EPS (₹)	4.7	4.7
TTM Sales (₹ Cr.)	879	909
BVPS (₹.) ⓘ	52.9	52.7
Reserves (₹ Cr.) ⓘ	715	711
P/BV ⓘ	5.46	5.49
PE ⓘ	61.26	61.50

From the Market
52 Week Low / High (₹)	140.60 / 301.95
All Time Low / High (₹)	12.00 / 298.45
Market Cap (₹ Cr.)	3,977
Equity (₹ Cr.)	13.8
Face Value (₹)	1
Industry PE ⓘ	40.2

Management X-Ray of Artemis Medicare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

44.53

* Pledged shares as % of Promoter's holding (%)

Valuation of Artemis Medicare

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Artemis Medicare

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	367	402	459	503	547	563	402	545	714	845
Operating Expenses ⓘ	325	359	407	443	482	501	367	479	621	717
Manufacturing Costs	143	158	181	209	231	238	156	208	294	347
Material Costs	98	106	120	122	131	138	115	153	185	210
Employee Cost	57	70	77	90	97	102	82	102	117	134
Other Costs ⓘ	27	24	29	22	23	22	14	16	25	26
Operating Profit ⓘ	42	43	52	59	64	62	35	66	94	128
Operating Profit Margin (%)	11.4%	10.8%	11.3%	11.8%	11.7%	11.1%	8.7%	12.1%	13.1%	15.2%
Other Income ⓘ	3	5	5	4	4	5	4	5	7	7
Interest ⓘ	12	9	9	9	11	13	12	11	19	30
Depreciation ⓘ	12	12	15	18	20	22	21	21	29	38
Exceptional Items ⓘ	0	0	0	0	0	0	3	0	0	0
Profit Before Tax ⓘ	21	27	32	35	37	32	9	39	53	68
Tax ⓘ	3	6	5	9	16	12	2	6	13	19
Profit After Tax	19	22	27	27	21	20	7	33	40	49
PAT Margin (%)	5.1%	5.4%	5.9%	5.3%	3.8%	3.6%	1.8%	6.0%	5.6%	5.8%
Adjusted EPS (₹)	0.9	1.0	1.3	1.3	0.0	1.5	0.5	2.5	3.0	3.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	15%	12%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	156	184	204	231	280	314	322	354	398	445
Share Capital ⓘ	21	21	21	21	0	13	13	13	13	14
Reserves ⓘ	135	163	183	210	280	301	308	341	385	432
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	58	50	66	52	91	71	99	153	198	216
Long Term Debt	58	50	66	52	53	61	99	153	198	216
Short Term Debt	0	0	0	0	38	11	0	0	0	0
Trade Payables	52	55	62	67	74	74	56	58	83	89
Others Liabilities ⓘ	65	56	91	101	109	122	121	149	227	228
Total Liabilities ⓘ	331	345	422	452	555	581	597	713	907	978
Fixed Assets
Gross Block	309	331	379	341	434	461	462	585	719	855
Accumulated Depreciation	70	82	97	33	53	74	90	109	135	156
Net Fixed Assetsⓘ	239	249	283	309	381	387	372	476	584	699
CWIP ⓘ	0	1	27	43	49	56	81	64	95	33
Investmentsⓘ	0	0	0	0	0	2	4	6	12	15
Inventories	7	6	6	6	7	11	9	12	13	9
Trade Receivables	40	54	60	56	79	77	53	70	85	83
Cash Equivalents	24	6	10	12	12	15	29	27	48	58
Others Assetsⓘ	21	28	36	26	26	34	49	59	71	80
Total Assets ⓘ	331	345	422	452	555	581	597	713	907	978

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	53	20	58	72	41	56	27	61	129	108
PBT ⓘ	21	27	32	35	37	32	9	39	53	68
Adjustment ⓘ	23	15	19	14	26	34	29	36	46	56
Changes in Working Capital ⓘ	10	-21	8	24	-13	-5	-8	2	33	-12
Tax Paid ⓘ	-1	0	-1	-1	-10	-4	-2	-16	-2	-5
Cash Flow From Investing Activity ⓘ	-10	-14	-74	-67	-50	-22	-34	-106	-153	-89
Capex	-16	-17	-75	-61	-57	-19	-25	-106	-134	-71
Net Investments	5	0	0	-7	6	-1	-8	0	-15	-18
Others ⓘ	1	3	2	1	1	-1	-1	0	-4	1
Cash Flow From Financing Activityⓘ	-35	-24	19	-10	14	-33	13	44	30	-27
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-25	-17	27	-2	-15	6	36	55	51	14
Interest Paid ⓘ	-11	-7	-8	-7	-9	-10	-10	-8	-15	-25
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	-6
Others ⓘ	0	0	0	0	38	-28	-13	-3	-6	-10
Net Cash Flow ⓘ	7	-18	3	-4	5	2	6	-2	7	-8

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	24.93	22.87	22.15	17.57	10.88	8.83	2.82	12.02	12.85	13.88
ROCE (%)	19.21	21.15	20.59	18.36	16.05	13.02	5.93	11.89	13.87	16.48
Asset Turnover Ratio	1.14	1.19	1.2	1.15	1.09	0.99	0.68	0.83	0.88	0.9
PAT to CFO Conversion(x)	2.79	0.91	2.15	2.67	1.95	2.8	3.86	1.85	3.23	2.2
Working Capital Days
Receivable Days	34	42	45	42	45	50	59	41	39	36
Inventory Days	6	6	5	5	4	6	9	7	6	5
Payable Days	176	184	177	193	197	195	206	136	139	150

Artemis Medicare Services Ltd Stock News

Artemis Medicare Services Ltd FAQs

What is the share price of Artemis Medicare?

Company share prices are keep on changing according to the market conditions. The closing price of Artemis Medicare on 21-Nov-2024 14:23 is ₹320.4.

What is the market cap of Artemis Medicare?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 14:23 the market cap of Artemis Medicare stood at ₹3,976.7.

What is the P/E ratio of Artemis Medicare?

The latest P/E ratio of Artemis Medicare as of 21-Nov-2024 14:23 is 61.26.

What is the P/B ratio of Artemis Medicare?

The latest P/B ratio of Artemis Medicare as of 21-Nov-2024 14:23 is 5.46.

What is the 52-week high and low of Artemis Medicare?

The 52-week high of Artemis Medicare is ₹301.9 and the 52-week low is ₹140.6.

What is the TTM revenue of Artemis Medicare?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Artemis Medicare is ₹878.7 ( Cr.) .

About Artemis Medicare Services Ltd

Artemis Medicare Services Limited was incorporated on May 18, 2004. The Company commenced its commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on 16th July, 2007.

Artemis Health Institute, established in 2007, is a healthcare venture launched by the promoters of the Apollo Tyres Group. Artemis is the first Hospital in Gurgaon to get accredited by Joint Commission International (JCI) (in 2013). It is the first Hospital in Haryana to get NABH accreditation within 3 years of start up.

Designed as one of the most advanced in India, Artemis provides a depth of expertise in the spectrum of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services. Artemis has put modern technology in the hands of renowned from across the country and abroad to set new standards in healthcare. The medical practices and procedures followed in the hospital are research oriented and benchmarked against the best in the world. Top-notch services, in a warm, open centric environment, clubbed with affordability, has made it one of the most revered hospitals in the country.

Business area of the company

The Company is engaged in the business of managing and operating of multi specialty hospitals.

Awards

2020: First position in CII National HR Circle Competition (Stream: Innovative Leadership during Crisis)by Confederation of Indian Industry (CII)
2019: Kayakalp Award for Excellence in promoting cleanliness, hygiene and infection control by Quality Council of India in association with Ministry of Health and Family Welfare, Government Of India
2019: Healthcare HR Excellence Award by Rxcruit
2019: Indian Healthcare Excellence Awardby Brands Win
2019: Excellence in Healthcare Award at “India’s Most Trusted Healthcare Awards 2019” (Best Bone Marrow Transplant Centre in North India) by My Brand Better
2019: One of India's Top 50 Companies with GPMS (Great People Managers Study) by Great Manager Institute in association with Forbes India
2019: D.L. Shah Quality Silver Award - For the case study End to End Care Delivery by Quality Council of India
2018: FICCI Healthcare Excellence Award 2018 for Service Excellence by FICCI Healthcare
2018: Award for Excellence in Healthcare by The Healthcare Today
2018: Best Multi Super Specialty Hospital in Delhi NCR by Health Care Awards
2017: Best Super Specialty Hospital in Delhi - NCR by Indian Excellence Award 2017
2017: Best Hospital in Quality Treatment - State Health Awards by IMA Punjab & AHPI
2017: Healthcare Transformation Awards - Mobile Innovations in healthcare by NASSCOM dynamic CIO.